tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Balance Sheet

731 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q4 2024 were $666.37M, an increase of 128.15% from the previous quarter. IMVT total liabilities were $48.61M for the fiscal quarter, a 20.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Assets
$ 666.37M$ 405.84M$ 515.23M$ 412.49M$ 109.39M
Total Liabilities
$ 48.61M$ 43.34M$ 45.74M$ 21.01M$ 15.32M
Total Equity Gross Minority
$ 617.76M$ 362.49M$ 469.82M$ 391.48M$ 94.07M
Total Capitalization
$ 617.76M$ 362.54M$ 469.82M$ 391.48M$ 94.07M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 3.42M$ 0.00
Currency in USD

Immunovant Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis